PRODUCTS RANGE
- AFB
- Alpha Beta Lar
- PRODUCTS
- Azofen
- Beclolar NC
- Betalar
- Bowlease
- Cefaxil
- Ciprolar
- Clavimox
- Clobelar
- Clofcin
- Control
- Dentalar
- Dica
- Dolar
- Faminex
- Fazim
- Fifolar
- Flatulex
- Flox
- Infa-VT
- Kinase
- Klean V
- Koxylar
- Larbro
- Larfan
- Largyl
- Larkin
- Metlar
- Montelar
- Nolice
- Pmox
- Moxylar
- Pandom
- Noldepin
- Piplar
- Skylone
- Utrok
- Toko
- Zeepain
- Pymolar
- Queenolar
- Rashnil
- Richzyme
- SAP
- Spasmolar
- Symolar
LATEST NEWS
2002-03-12
Merck Resolves Vioxx Litigation in Canada
2012-02-03
Merck to Present at the 30th Annual J.P. Morgan Healthcare Conference
2002-03-12
FDA Approves Merck’s ISENTRESS (raltegravir) for Use in Children Ages Two Years and Older as
2023-08-12
qqq
2023-08-12
dd11
Montelar
| Montelar Tablet Active Ingredient "Montelukast 10 mg + Levocetirizine 5 mg" Pack Detail 1*10 Therapy Antiasthmatic & antiallergic |
 |
Montelar Kid Tablet
Active Ingredient
"Montelukast 4 mg + Levocetirizine 2.5 mg"
Pack Detail
1*10
Therapy
Antiasthmatic & antiallergic